Watson Pharmaceuticals Inc.

Nov 16, 09
	NEW STORY
07:00 ET	Watson Names Robert A. Stewart Senior Vice President, Global Operations
Nov 10, 09
21:12 ET	Watson Announces Presentation Time Change at Credit Suisse Healthcare Conference
Nov 06, 09
16:00 ET	Watson to Present at Credit Suisse Healthcare Conference
Nov 04, 09
07:30 ET	Watson Reports Third Quarter 2009 GAAP EPS of $0.55; Adjusted EPS of $0.66
Oct 30, 09
07:30 ET	Watson Names R. Todd Joyce Senior Vice President and Chief Financial Officer; Succeeds Mark W. Durand
Oct 28, 09
08:00 ET	Watson and Barr Settle Lawsuit Over Oxytrol(R)
Sep 21, 09
08:00 ET	Watson Names G. Frederick Wilkinson Executive Vice President, Global Brands
Aug 28, 09
16:01 ET	Watson Pharmaceuticals Receives FDA Approval for Generic PLAN B(R) for Over-the-Counter Use
Aug 18, 09
17:09 ET	Watson Prices $850 Million of Senior Unsecured Notes
09:01 ET	Watson Announces Offering of Senior Unsecured Notes
Aug 07, 09
17:01 ET	Watson Announces Limited Recall Of Fentanyl Transdermal System
Aug 06, 09
18:08 ET	Watson Pharmaceuticals and Arrow Group Receive FTC Second Request
Aug 03, 09
16:00 ET	Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL(R) 25 MG and 50 MG
Jul 29, 09
07:05 ET	Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook
Jul 28, 09
16:00 ET	Watson Announces License Agreement With GeneraMedix for Generic Version of Ferrlecit(R)
Jul 27, 09
16:40 ET	Watson CFO Mark W. Durand to Take Leave of Absence
Jul 15, 09
08:00 ET	Watson Confirms Filing of Abbreviated New Drug Application for Generic Sanctura XR(R)
Jul 14, 09
07:45 ET	Watson Pharmaceuticals Receives a Complete Response Letter for Its 24-Week Formulation of TRELSTAR(R) (triptorelin pamoate) NDA from US FDA
Jul 10, 09
08:05 ET	Watson Pharmaceuticals Resumes Shipment of INFeD(R) (Iron Dextran Injection, USP)
08:00 ET	Watson to Host Second Quarter 2009 Earnings Conference Call and Webcast
Jul 08, 09
16:00 ET	Watson Pharmaceuticals Receives FDA Approval for Fruit and Cinnamon Flavored Coated Nicotine Gums
Jun 29, 09
08:00 ET	Watson Pharmaceuticals Appoints Christopher W. Bodine to Board of Directors
Jun 24, 09
17:48 ET	Watson Pharmaceuticals Receives FDA Approval For Generic PLAN B(R)
Jun 17, 09
07:30 ET	Watson to Acquire Arrow Group
Jun 10, 09
06:45 ET	Watson Files FDA Application for Generic Mucinex(R) D
May 18, 09
09:30 ET	Watson Provides Update on Ferrlecit(R) Supply and Distribution Agreement
May 08, 09
07:50 ET	RAPAFLO(TM) (silodosin) Provides Rapid and Sustained Benign Prostatic Hyperplasia (BPH) Symptom Relief in as Little as Three Days
Apr 30, 09
07:00 ET	Watson Pharmaceuticals Reports First Quarter 2009 Results; Raises 2009 Outlook
Apr 28, 09
08:00 ET	Watson Confirms Filing of Abbreviated New Drug Application for Generic Enablex(R)
Apr 22, 09
08:05 ET	Watson Files FDA Applications for Generic Mucinex(R)
08:00 ET	Watson to Host and Webcast Investment Community Meeting at American Urological Association Annual Meeting
Mar 31, 09
16:00 ET	Delaware Court Rules That Watson Does Not Infringe Patent Related to Generic Version of Concerta(R) and Declares Patent Invalid
Mar 06, 09
18:13 ET	Watson Pharmaceuticals and Elan Settle Lawsuit Over Naproxen Sodium
Feb 19, 09
07:00 ET	Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook
Feb 02, 09
07:00 ET	Watson Acknowledges Federal Trade Commission Action Regarding AndroGel Patent Settlement
Jan 12, 09
07:00 ET	Warner Chilcott and Watson Pharmaceuticals Announce Agreements on Loestrin(R) 24 and Femcon(R) Fe Patent Litigation
Dec 31, 08
07:00 ET	Watson Pharmaceuticals Receives FDA Approval for Mint Coated Nicotine Gum
Dec 29, 08
20:50 ET	Watson Pharmaceuticals Receives FDA Final Approval for Generic Mircette(R)
Dec 16, 08
08:00 ET	Watson Pharmaceuticals Receives FDA Approval for Generic Razadyne(R) ER Capsules
Nov 26, 08
16:00 ET	Watson Pharmaceuticals Receives FDA Final Approval for Generic Wellbutrin XL(R) 150 mg
Nov 25, 08
08:00 ET	Watson Enters Into Agreement to Acquire Products Related to Teva's Proposed Acquisition of Barr
Nov 13, 08
16:00 ET	Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer
Oct 29, 08
07:00 ET	Watson Pharmaceuticals Reports Third Quarter 2008 Results
Oct 09, 08
08:30 ET	UPDATE: Watson Receives US FDA Approval for RAPAFLO(TM) (silodosin) for the Treatment of Benign Prostatic Hyperplasia (BPH)
Oct 08, 08
18:00 ET	Watson Receives US FDA Approval for RAPAFLO(TM) (silodosin) for the Treatment of Benign Prostatic Hyperplasia (BPH)
08:30 ET	Watson Announces Positive Data for Its Investigational Oxybutynin Topical Gel for the Treatment of Overactive Bladder at SUNA's Annual Conference
Oct 01, 08
17:03 ET	Watson Notified of OXYTROL(R) Patent Challenge
Sep 29, 08
08:30 ET	Watson Announces Positive Data for RAPAFLO(TM)(silodosin), Its Investigational Product for BPH, at Regional AUA Conferences
Aug 13, 08
21:46 ET	Watson Announces District Court Ruling in Naproxen Sodium Patent Suit
Aug 08, 08
20:53 ET	Watson Announces Limited Recall of Fentanyl Transdermal System
Aug 06, 08
07:00 ET	Watson Pharmaceuticals Reports Second Quarter 2008 Results
Aug 05, 08
08:00 ET	Urologists Should Recognize the Cardiac Safety of Prescribed Medications, Article Concludes
Jul 28, 08
17:16 ET	Mylan Acquires Remaining Interest in Somerset Joint Venture From Watson
08:00 ET	Watson Names Clare Carmichael Senior VP Human Resources
Jul 25, 08
08:00 ET	Watson Launches Omeprazole Delayed-Release Capsules, 40MG
Jun 30, 08
10:06 ET	Watson Launches Generic MARINOL(R) Capsules
Jun 03, 08
07:30 ET	Watson Receives FDA Approval of Potassium Chloride Extended-Release Capsules
Jun 02, 08
08:00 ET	Watson Receives Final Approval of Omeprazole Delayed-Release Capsules
May 28, 08
03:00 ET	Watson Announces Oxybutynin Topical Gel NDA Accepted for Filing by FDA for the Treatment of Overactive Bladder
May 23, 08
17:58 ET	Watson to Present at the UBS Global Specialty and Generic Pharmaceuticals Conference
May 21, 08
09:00 ET	Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
May 13, 08
08:30 ET	Watson to Host and Webcast Investment Community Meeting at American Urological Association Annual Meeting
May 12, 08
08:00 ET	Watson Pharmaceuticals Announces Appointment of Andrew L. Turner as Chairman of the Board of Directors
May 09, 08
16:44 ET	Watson to Present at the Bank of America 2008 Healthcare Conference
May 06, 08
08:00 ET	Watson Pharmaceuticals to Webcast Its 2008 Annual Meeting of Stockholders
May 01, 08
07:00 ET	Watson Pharmaceuticals Reports First Quarter 2008 Results
Apr 30, 08
09:00 ET	FDA Approves MIXJECT(TM), a Convenient, Easy-to-Use Drug Delivery System For Watson Pharmaceutical's TRELSTAR(R) DEPOT and TRELSTAR(R) LA
Apr 24, 08
16:00 ET	Watson Files FDA Application for Generic FENTORA(R)
Mar 13, 08
16:00 ET	Watson Files FDA Application for Generic LYBREL(R)
Mar 04, 08
16:04 ET	Watson Files Application for Generic SEASONIQUE(R)
Feb 20, 08
07:00 ET	Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook
Feb 13, 08
16:00 ET	Watson Pharmaceuticals Announces FDA Inspection of Florida Facilities
Feb 07, 08
16:00 ET	Watson Names Francois Menard Senior VP Generics Research and Development
Feb 05, 08
07:00 ET	Watson to Distribute Alendronate Tablets
Feb 01, 08
16:00 ET	Watson to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
Jan 24, 08
08:05 ET	Watson to Host Fourth Quarter and Full Year 2007 Earnings Conference Call and Webcast
Jan 07, 08
16:00 ET	Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
Jan 03, 08
08:00 ET	Watson Launches Generic Biaxin(R) XL
Jan 02, 08
08:00 ET	Watson Receives FDA Approval for Generic DuoNeb(R)
Dec 14, 07
13:56 ET	Watson Confirms Patent Litigation With Barr Related to Seasonale(R)
Dec 06, 07
16:41 ET	Watson and Novartis Settle Lawsuit Over Exelon(R) Patent Litigation
Dec 04, 07
07:05 ET	Watson and Biovail Settle Lawsuit Over Cardizem(R) LA
Nov 27, 07
08:00 ET	Watson Receives FDA Approval For Generic Combunox(R)
Nov 16, 07
07:00 ET	Watson Names Mark Durand Chief Financial Officer
Nov 07, 07
07:00 ET	Watson Files FDA Application for Generic YAZ(R)
Nov 06, 07
07:00 ET	Watson Pharmaceuticals Reports Third Quarter 2007 Results
Oct 08, 07
08:00 ET	Watson to Host Third Quarter 2007 Earnings Conference Call and Webcast
Oct 03, 07
08:00 ET	Watson Files Application for Generic FEMCON(R) Fe
Sep 26, 07
08:00 ET	Watson Receives FDA Approval for Generic Accuneb(R)
Sep 04, 07
16:05 ET	Watson to Present at the Bear Stearns 20th Annual Healthcare Conference
08:00 ET	Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
Aug 21, 07
09:00 ET	Watson Receives FDA Approval For Generic Duragesic(R)
Aug 02, 07
06:55 ET	Watson Announces CEO Succession Plan
06:50 ET	Watson Pharmaceuticals Reports Second Quarter 2007 Results
Jul 23, 07
05:00 ET	Watson to Host Second Quarter 2007 Earnings Conference Call and Webcast
Jun 13, 07
17:09 ET	Watson Receives FDA Final Approval for Generic Wellbutrin XL(R) 300 Mg
Jun 05, 07
16:00 ET	Watson to Present at the Goldman Sachs Twenty-Eighth Annual Global Healthcare Conference
May 23, 07
08:00 ET	Watson Pharmaceuticals to Present at the Bank of America 2007 Health Care Conference
May 21, 07
08:00 ET	Watson Enters Into Agreement to Permit Sandoz to Launch Metoprolol Succinate Extended-Release 50 mg Tablets; Relinquishes 180-Day Market Exclusivity
May 01, 07
16:05 ET	Watson Pharmaceuticals Reports First Quarter 2007 Results
Apr 27, 07
07:00 ET	Watson Pharmaceuticals to Webcast Its 2007 Annual Meeting of Stockholders
Apr 25, 07
11:00 ET	Watson to Host First Quarter 2007 Earnings Conference Call and Webcast
Apr 09, 07
07:00 ET	Watson Pharmaceuticals to Present at the CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference
Mar 16, 07
12:41 ET	Watson Pharmaceuticals to Present at the Lehman Brothers Tenth Annual Global Healthcare Conference
Feb 27, 07
16:05 ET	Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2006 Results
Feb 12, 07
08:00 ET	Watson and GlaxoSmithKline Settle Lawsuit Over Wellbutrin Xl(R)
Feb 01, 07
16:05 ET	Watson to Host Fourth Quarter and Full Year 2006 Earnings Conference Call and Webcast
Jan 16, 07
08:58 ET	Watson Announces Positive Phase 3 Study Results on Silodosin for Treatment of Benign Prostatic Hyperplasia
Dec 11, 06
09:00 ET	Watson Appoints Thomas Giordano as Senior Vice President, Chief Information Officer
Nov 14, 06
16:05 ET	Watson Pharmaceuticals to Present at the Credit Suisse 2006 Healthcare Conference
Nov 07, 06
16:05 ET	Watson Pharmaceuticals Reports Third Quarter 2006 Results
Nov 06, 06
06:30 ET	Watson Completes Acquisition of Andrx
Nov 03, 06
08:15 ET	Watson to Present at the CIBC World Markets 17th Annual Healthcare Conference
Oct 31, 06
16:02 ET	Watson Receives FTC Clearance for Andrx Acquisition
Oct 18, 06
08:05 ET	Watson Certifies Substantial Compliance With FTC Second Request
Oct 10, 06
18:14 ET	Watson to Host Third Quarter 2006 Earnings Conference Call and Webcast
08:05 ET	Watson Pharmaceuticals Announces Resignation of Chief Financial Officer
Sep 13, 06
16:45 ET	Watson and Unimed Pharmaceuticals, Inc. Settle Lawsuit Over AndroGel(R) Testosterone Gel
Sep 07, 06
08:00 ET	Watson Pharmaceuticals Receives FDA Final Approval for Generic Seasonale(R)
Sep 05, 06
08:05 ET	Watson Names Thomas Russillo as President, U.S. Generics Division
Aug 08, 06
16:05 ET	Watson Pharmaceuticals Reports Second Quarter 2006 Results
Jul 14, 06
16:05 ET	Watson to Host Second Quarter 2006 Earnings Conference Call and Webcast
Jun 09, 06
18:43 ET	Watson Pharmaceuticals to Present at the Goldman Sachs Global Healthcare Conference
Jun 01, 06
17:10 ET	Watson Pharmaceuticals Receives FDA Approval for Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.1mg / 0.02mg
May 12, 06
16:00 ET	Watson Pharmaceuticals to Present at the Bank of America 2006 Health Care Conference
May 09, 06
16:49 ET	Watson Pharmaceuticals Receives FDA Tentative Approval for Generic Seasonale(R)
07:15 ET	Watson Pharmaceuticals Reports First Quarter 2006 Results
May 03, 06
06:15 ET	Watson Pharmaceuticals to Host First Quarter 2006 Earnings Conference Call and Webcast
06:00 ET	Watson Pharmaceuticals and Andrx Corporation Receive FTC Second Request
May 01, 06
16:00 ET	Watson Pharmaceuticals to Webcast Its 2006 Annual Meeting of Stockholders
Apr 25, 06
08:05 ET	Watson Pharmaceuticals Launches Pravastatin Tablets
Apr 13, 06
16:05 ET	Watson Completes Acquisition of Mumbai-Based Sekhsaria Chemicals Ltd.
Apr 03, 06
08:15 ET	Watson Pharmaceuticals to Present at the CIBC Annual Biotechnology and Specialty Pharmaceuticals Conference
Mar 30, 06
08:05 ET	Watson Pharmaceuticals to Divest Injectable Manufacturing Facility in Arizona
Mar 13, 06
07:01 ET	Watson to Acquire Andrx For $1.9 Billion, Creating the Third Largest Specialty Pharmaceutical Company In the U.S.
Feb 16, 06
16:07 ET	Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2005 Results
Feb 07, 06
18:00 ET	Watson Pharmaceuticals to Host Meeting to Discuss Fourth Quarter and Full Year 2005 Results
Jan 30, 06
08:32 ET	Watson Pharmaceuticals Receives FDA Approval for Testosterone Gel Product
Jan 09, 06
12:17 ET	Watson Pharmaceuticals to Present at the 24th Annual JPMorgan Healthcare Conference
Nov 15, 05
12:04 ET	Watson Pharmaceuticals to Present at the Credit Suisse First Boston Annual Healthcare Conference
Nov 04, 05
17:14 ET	Watson Pharmaceuticals to Present at the CIBC World Markets 16th Annual Healthcare Conference
Nov 02, 05
16:06 ET	Watson Pharmaceuticals Reports Third Quarter 2005 Results
Oct 18, 05
16:30 ET	Watson Pharmaceuticals Named Exclusive Distributor of Authorized Generic OxyContin(R) Tablets
Oct 12, 05
08:05 ET	Watson Pharmaceuticals to Host Third Quarter 2005 Earnings Conference Call and Webcast
Sep 13, 05
08:31 ET	Watson Pharmaceuticals Announces Completion of $300 Million Share Repurchase Program
Sep 07, 05
17:26 ET	Watson Pharmaceuticals to Present at the Bear Stearns 18th Annual Healthcare Conference
Aug 01, 05
08:01 ET	Watson Pharmaceuticals Receives FDA Approval for Desogestrel and Ethinyl Estradiol Tablets USP, 0.15MG / 0.03MG
Jul 27, 05
16:05 ET	Watson Pharmaceuticals Reports Second Quarter 2005 Results
Jul 14, 05
08:03 ET	Watson Pharmaceuticals to Host Second Quarter 2005 Earnings Conference Call and Webcast
Jun 16, 05
07:00 ET	Somerset Files Response to EMSAM(R) Action Letter
Jun 13, 05
08:02 ET	Watson Pharmaceuticals Commences Phase 3 Studies on Silodosin for Treatment of Benign Prostatic Hyperplasia
Jun 10, 05
16:00 ET	Watson Pharmaceuticals to Present at the Goldman Sachs 26th Annual Global Healthcare Conference
May 16, 05
09:00 ET	Watson Pharmaceuticals to Present at the Banc of America Securities Health Care Conference 2005
May 09, 05
16:05 ET	Watson Pharmaceuticals to Webcast Its 2005 Annual Meeting of Stockholders
May 05, 05
16:05 ET	Watson Pharmaceuticals Reports First Quarter 2005 Results
Apr 25, 05
08:03 ET	Watson Pharmaceuticals to Host First Quarter 2005 Earnings Conference Call and Webcast
Apr 18, 05
08:02 ET	Watson Pharmaceuticals Names Edward F. Heimers, Jr. President of Watson's Brand Division
Apr 04, 05
07:02 ET	Watson Pharmaceuticals' TRELSTAR(R) DEPOT and TRELSTAR(R) LA (Triptorelin Pamoate for Injectable Suspension) Now Available Nationwide
Mar 28, 05
16:00 ET	Watson Pharmaceuticals to Present at the Lehman Brothers Eighth Annual Global Healthcare Conference
Mar 14, 05
08:01 ET	Watson Pharmaceuticals to Present at the SG Cowen & Co. 25th Annual Healthcare Conference
Feb 10, 05
16:10 ET	Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2004 Results
Feb 03, 05
06:01 ET	Watson Pharmaceuticals to Host Fourth Quarter and Full Year 2004 Earnings Conference Call and Webcast
Jan 07, 05
07:00 ET	Watson Pharmaceuticals to Present at the 23rd Annual JPMorgan Healthcare Conference
Dec 22, 04
16:00 ET	Watson Pharmaceuticals Launches Generic Bupropion Hydrochloride Sustained-Release 200mg Tablets
Nov 22, 04
11:28 ET	Watson Pharmaceuticals Receives FDA Approval For Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.1MG / 0.02MG
07:15 ET	Watson Pharmaceuticals Receives FDA Approval Forlevonorgestrel and Ethinyl Estradiol Tablets USP, 0.1MG / 0.02MG
07:01 ET	Watson Pharmaceuticals to Present at the Lazard Life Sciences Conference
Nov 08, 04
07:01 ET	Watson Pharmaceuticals Receives FDA Approval for Citalopram Hydrobromide Tablets 10MG, 20MG and 40MG
Nov 04, 04
16:08 ET	Watson Pharmaceuticals to Present at the CIBC World Markets 15th Annual Healthcare Conference
Oct 27, 04
16:06 ET	Watson Pharmaceuticals Reports Third Quarter 2004 Results
Oct 25, 04
07:01 ET	Watson Pharmaceuticals Announces Senior Management Change
Oct 20, 04
16:16 ET	Watson Pharmaceuticals to Host Third Quarter 2004 Earnings Conference Call and Webcast
Oct 05, 04
09:01 ET	Watson Pharmaceuticals Provides Update on Genelabs Technologies' Clinical Trial GL02-01 in Women With Systemic Lupus Erythematosus
Sep 29, 04
04:00 ET	Watson Pharmaceuticals and Debiopharm S.A. Enter Into an Exclusive Licensing Agreement for Two Approved Urology Products - TRELSTAR(R) DEPOT and TRELSTAR(R) LA
Sep 20, 04
16:05 ET	Watson Pharmaceuticals to Present at the Banc of America Securities 34th Annual Investment Conference
Sep 08, 04
07:01 ET	Watson Pharmaceuticals to Present at the Bear Stearns 17th Annual Healthcare Conference
Aug 03, 04
07:03 ET	Watson Pharmaceuticals Reports Second Quarter 2004 Results
Aug 02, 04
16:05 ET	Watson Pharmaceuticals Receives FDA Approval for Mint Flavor Nicotine Gum
Jul 21, 04
16:34 ET	Watson Names James Nash as Executive Vice President, Supply Chain
Jul 19, 04
12:18 ET	Watson Pharmaceuticals to Host Second Quarter 2004 Earnings Conference Call and Webcast
Jun 28, 04
06:05 ET	Watson Pharmaceuticals Refocuses Business Strategy
06:02 ET	Watson Pharmaceuticals Updates Second Quarter and Full Year 2004 Estimates
Jun 23, 04
16:42 ET	Health Canada Approves Watson Pharmaceuticals' OXYTROL(R) for the Treatment of Overactive Bladder
Jun 21, 04
03:00 ET	Watson Pharmaceuticals' Transdermal Therapy for Urge Incontinence Approved for Marketing in the European Union
Jun 16, 04
08:05 ET	Watson Pharmaceuticals Receives New Patent on OXYTROL(R)
08:01 ET	Watson Pharmaceuticals Announces Launch of New Acute Pain Product in Collaboration With Interpharm
Jun 03, 04
16:29 ET	Watson Pharmaceuticals to Present at the Goldman Sachs 25th Annual Global Healthcare Conference
May 28, 04
19:32 ET	Watson Pharmaceuticals Launches Generic Zyban(R)
May 14, 04
13:25 ET	Watson Pharmaceuticals to Present at the Banc of America Securities 2004 Healthcare Conference
May 12, 04
07:02 ET	Watson Pharmaceuticals to Webcast Its 2004 Annual Meeting of Stockholders
May 07, 04
13:02 ET	Watson Pharmaceuticals to Present at the Credit Suisse First Boston Specialty Pharmaceuticals/Generics Conference
May 04, 04
13:28 ET	Watson Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Apr 28, 04
16:17 ET	Watson Pharmaceuticals Reports First Quarter 2004 Results
Apr 26, 04
06:02 ET	Watson Pharmaceuticals Announces Senior Management Departure
Apr 22, 04
07:08 ET	Watson Pharmaceuticals Announces Agreement With Kissei for Novel Urology Drug Candidate
06:03 ET	Watson Pharmaceuticals to Host First Quarter 2004 Earnings Conference Call and Webcast
Apr 15, 04
07:07 ET	Watson Pharmaceuticals Announces Vacating of Consent Decree at Its Steris Laboratories Facility
Apr 08, 04
16:11 ET	Watson Pharmaceuticals Launches Terconazole Vaginal Cream 0.8%
Mar 26, 04
17:01 ET	Watson Pharmaceuticals Appoints Catherine M. Klema to Board of Directors
16:49 ET	Watson Pharmaceuticals Appoints Catherine M. Klemato Board Of Directors
Mar 24, 04
09:34 ET	Watson Pharmaceuticals Launches Generic Macrobid(R)
Mar 22, 04
16:30 ET	Watson Pharmaceuticals Launches Generic Bupropion HCL Sustained-Release 150mg
Mar 15, 04
09:04 ET	Watson Names Gordon Munro, Ph.D., Senior Vice President, Quality Assurance
Mar 09, 04
08:33 ET	Watson Pharmaceuticals Announces Expiration of Tender Offer for 7 1/8% Senior Notes
Mar 05, 04
09:39 ET	Watson Pharmaceuticals to Present at the SG Cowen Securities 24th Annual Healthcare Conference
Mar 01, 04
16:46 ET	Watson Pharmaceuticals to Present at the Lehman Brothers Healthcare Conference
07:05 ET	Watson Pharmaceuticals to Present at the Raymond James 25th Annual Institutional Investors Conference
Feb 25, 04
07:01 ET	Watson Pharmaceuticals Announces Agreement With Novartis Consumer Health, Inc.
Feb 20, 04
17:41 ET	Watson Pharmaceuticals Announces Receipt of Required Consents in Connection With Tender Offer for 7 1/8 Percent Senior Notes
08:04 ET	Watson Pharmaceuticals to Present at the Fourth Annual Smith Barney Citigroup Specialty Pharmaceuticals Conference
Feb 05, 04
16:06 ET	Watson Pharmaceuticals Reports Earnings Per Share Of $0.48 for Fourth Quarter 2003
16:02 ET	Watson Pharmaceuticals Announces Tender Offer To Repurchase Its 7 1/8% Senior Notes
Jan 29, 04
17:05 ET	Watson Pharmaceuticals to Host Meeting to Discuss Fourth Quarter and Full Year 2003 Results
Jan 16, 04
07:01 ET	Watson Pharmaceuticals Launches Generic Bupropion HCl Sustained Release 100mg
Jan 08, 04
07:03 ET	Watson Pharmaceuticals Enters Into Licensing Agreement With Paladin for OXYTROL(R) in Canada
Jan 07, 04
16:30 ET	Watson Pharmaceuticals to Present at the 22nd Annual JPMorgan Healthcare Conference
Dec 29, 03
16:26 ET	Watson Pharmaceuticals Launches TriNessa(TM) Oral Contraceptive
Dec 12, 03
08:00 ET	Watson Pharmaceuticals Reports Receipt of Subpoena From Office of Inspector General
Dec 10, 03
17:06 ET	Watson Pharmaceuticals Announces Preliminary Results From Phase III Onychomycosis Trials
Nov 28, 03
07:00 ET	Watson Pharmaceuticals Expands Alliance with Cipla Ltd.
Nov 24, 03
07:00 ET	Watson Pharmaceuticals' OXYTROL(R) Receives Positive Opinion for Approval in the European Union
Nov 19, 03
16:17 ET	Watson Pharmaceuticals Launches Generic Glucotrol XL(R) 5 mg and 10 mg Tablets
Nov 10, 03
07:02 ET	Watson Pharmaceuticals Receives FDA Final Approval for Generic Glucotrol XL(R) 10 mg Tablets
Nov 06, 03
17:30 ET	Watson Pharmaceuticals to Present At The Fourteenth Annual CIBC Healthcare Conference
Nov 05, 03
07:02 ET	Watson Pharmaceuticals Reports Earnings Per Share Growth of 24 Percent To $0.47 for Third Quarter 2003
Oct 28, 03
09:07 ET	Watson Pharmaceuticals Acquires Research and Development Subsidiary From Amarin Corporation
Oct 21, 03
08:12 ET	Watson to Host Third Quarter 2003 Earnings Conference Call
Oct 20, 03
07:02 ET	Watson Pharmaceuticals Launches Generic Percocet(R) 7.5 Mg / 325 Mg and 10 Mg / 325 Mg
Sep 24, 03
02:00 ET	Watson Pharmaceuticals Announces European Commercialization Agreement With UCB Pharma for OXYTROL(TM)
Sep 16, 03
17:12 ET	Watson Pharmaceuticals to Present at The Banc of America Securities 33rd Annual Investment Conference
16:58 ET	Watson Receives FDA Final Approval for Nefazodone HCl
Sep 09, 03
09:46 ET	Watson Receives FDA Final Approval For Generic Glucotrol XL(R) 5 mg Tablets
Sep 08, 03
06:01 ET	Watson Receives FDA Approval for Generic Percocet(R) 7.5mg/325mg and 10mg/325mg
Sep 02, 03
16:15 ET	Watson Pharmaceuticals to Present at the Bear Stearns 16th Annual Healthcare Conference
Aug 27, 03
06:00 ET	Watson Pharmaceuticals Files Abbreviated New Drug Application For Generic AndroGel(R)
Aug 21, 03
09:02 ET	Mylan Laboratories and Watson Pharmaceuticals Announce FDA Acceptance of Resubmission of New Drug Application for EMSAM(TM) Antidepressant Patch
Aug 05, 03
07:02 ET	Watson Pharmaceuticals Reports Second Quarter 2003 Financial Results
Aug 04, 03
16:19 ET	Watson Launches Generic Ceftin(R)
Aug 01, 03
14:51 ET	Watson to Host Second Quarter 2003 Earnings Conference Call
Jun 19, 03
12:31 ET	Watson Receives FDA Approval for Generic Remeron(R)
Jun 16, 03
08:14 ET	Watson Names Ian McInnes, Ph.D. as Executive Vice President, Supply Chain
Jun 10, 03
16:46 ET	Watson Pharmaceuticals to Present at the Goldman Sachs 24th Annual Global Healthcare Conference
Jun 02, 03
16:42 ET	Watson Launches JOLIVETTE(TM) Oral Contraceptive
May 30, 03
16:22 ET	Watson Pharmaceuticals to Present at the UBS Warburg Global Specialty Pharmaceutical Conference
May 27, 03
16:30 ET	Watson Pharmaceuticals to Present at the Friedman Billings Ramsey Seventh Annual Technology and Growth Investor Conference
May 23, 03
09:00 ET	Watson's New Drug Submission for OXYTROL(TM) Accepted for Review in Canada
May 15, 03
19:00 ET	Watson Pharmaceuticals to Webcast Its 2003 Annual Meeting of Stockholders
May 06, 03
08:08 ET	Watson Pharmaceuticals Reports First Quarter 2003 Results
May 05, 03
08:10 ET	Watson Names Charles P. Slacik as Executive Vice President and Chief Financial Officer
08:08 ET	Watson Pharmaceuticals Expands Alliance With Cipla Ltd.
Apr 28, 03
18:27 ET	Watson to Host First Quarter 2003 Earnings Conference Call
09:06 ET	Watson Pharmaceuticals' OXYTROL(TM) Now Available Nationwide; Shipments to More Than 45,000 Pharmacies
Apr 25, 03
11:36 ET	Watson Pharmaceuticals to Present at the CIBC Annual Biotechnology & Specialty Pharmaceuticals Conference
Apr 08, 03
09:01 ET	Watson Launches Microgestin(R) Oral Contraceptive
Mar 25, 03
11:26 ET	Watson Pharmaceuticals to Present at the Banc of America Securities 2003 Healthcare Conference
Mar 18, 03
11:48 ET	Watson Pharmaceuticals to Present at the SG Cowen Securities Corporation 23rd Annual Health Care Conference
09:04 ET	Watson Pharmaceuticals & Ventiv Health, Inc. Announce U.S. Sales Force Agreement for OXYTROL(TM)
Mar 11, 03
16:26 ET	Watson Pharmaceuticals Announces European Filing for OXYTROL(TM)
Mar 10, 03
09:00 ET	Watson Pharmaceuticals Announces Closing of $500 Million Convertible Contingent Senior Debentures Offering
Mar 05, 03
08:04 ET	Watson Pharmaceuticals Announces Pricing of Convertible Senior Debentures Offering
Mar 04, 03
09:04 ET	Watson Obtains Commitment Letters for $300 Million Credit Facility
Mar 03, 03
17:29 ET	Watson Pharmaceuticals Announces Offering of Convertible Senior Debentures
Feb 28, 03
19:45 ET	Watson Pharmaceuticals to Present at the Salomon Smith Barney 3rd Annual Specialty Pharmaceuticals Conference
19:39 ET	Watson Pharmaceuticals to Present at the Lehman Brothers 6th Annual Global Healthcare Conference
Feb 26, 03
21:34 ET	FDA Approves Watson's OXYTROL(TM), The First and Only Transdermal Therapy for Overactive Bladder
Feb 06, 03
19:15 ET	Watson Pharmaceuticals Completes Purchase of Fiorinal(R) and Fioricet(R) Pain Product Lines
Feb 04, 03
08:07 ET	Watson Pharmaceuticals Reports Fourth Quarter and Year End 2002 Results
Jan 31, 03
12:26 ET	Watson Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
Jan 28, 03
11:28 ET	Watson to Host Fourth Quarter 2002 and Year-End Earnings Conference Call
Jan 27, 03
11:33 ET	Watson Launches Generic Mestinon(R)
Jan 23, 03
17:28 ET	Watson Provides 2003 Outlook for Continued Growth
Jan 22, 03
16:04 ET	Watson to Acquire Line of Pain Products
16:03 ET	Watson Launches MonoNessa(TM) Oral Contraceptive
Jan 15, 03
16:53 ET	Watson Updates Fourth Quarter 2002 Financial Estimates
Jan 09, 03
16:22 ET	Watson Launches Necon(R) 7/7/7 Oral Contraceptive
Jan 08, 03
08:04 ET	Watson Pharmaceuticals to Present at 21st Annual JPMorgan H&Q Healthcare Conference